CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for PAI-1

Abstract More than 70% of colorectal, prostate, ovarian, pancreatic and breast cancer specimens show expression of CD276 (B7–H3), a potential immune checkpoint family member. Several studies have shown that high CD276 expression in cancer cells correlates with a poor clinical prognosis. This has bee...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sibel Durlanik, Katrin Fundel-Clemens, Coralie Viollet, Heinrich J. Huber, Martin Lenter, Kerstin Kitt, Stefan Pflanz
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3514e95bf4724fdea484cf4f1f37996c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3514e95bf4724fdea484cf4f1f37996c
record_format dspace
spelling oai:doaj.org-article:3514e95bf4724fdea484cf4f1f37996c2021-12-02T17:57:16ZCD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for PAI-110.1038/s41598-021-94360-92045-2322https://doaj.org/article/3514e95bf4724fdea484cf4f1f37996c2021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94360-9https://doaj.org/toc/2045-2322Abstract More than 70% of colorectal, prostate, ovarian, pancreatic and breast cancer specimens show expression of CD276 (B7–H3), a potential immune checkpoint family member. Several studies have shown that high CD276 expression in cancer cells correlates with a poor clinical prognosis. This has been associated with the presence of lower tumor infiltrating leukocytes. Among those, tumor-associated macrophages can comprise up to 50% of the tumor mass and are thought to support tumor growth through various mechanisms. However, a lack of information on CD276 function and interaction partner(s) impedes rigorous evaluation of CD276 as a therapeutic target in oncology. Therefore, we aimed to understand the relevance of CD276 in tumor-macrophage interaction by employing a 3D spheroid coculture system with human cells. Our data show a role for tumor-expressed CD276 on the macrophage recruitment into the tumor spheroid, and also in regulation of the extracellular matrix modulator PAI-1. Furthermore, our experiments focusing on macrophage-expressed CD276 suggest that the antibody-dependent CD276 engagement triggers predominantly inhibitory signaling networks in human macrophages.Sibel DurlanikKatrin Fundel-ClemensCoralie ViolletHeinrich J. HuberMartin LenterKerstin KittStefan PflanzNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sibel Durlanik
Katrin Fundel-Clemens
Coralie Viollet
Heinrich J. Huber
Martin Lenter
Kerstin Kitt
Stefan Pflanz
CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for PAI-1
description Abstract More than 70% of colorectal, prostate, ovarian, pancreatic and breast cancer specimens show expression of CD276 (B7–H3), a potential immune checkpoint family member. Several studies have shown that high CD276 expression in cancer cells correlates with a poor clinical prognosis. This has been associated with the presence of lower tumor infiltrating leukocytes. Among those, tumor-associated macrophages can comprise up to 50% of the tumor mass and are thought to support tumor growth through various mechanisms. However, a lack of information on CD276 function and interaction partner(s) impedes rigorous evaluation of CD276 as a therapeutic target in oncology. Therefore, we aimed to understand the relevance of CD276 in tumor-macrophage interaction by employing a 3D spheroid coculture system with human cells. Our data show a role for tumor-expressed CD276 on the macrophage recruitment into the tumor spheroid, and also in regulation of the extracellular matrix modulator PAI-1. Furthermore, our experiments focusing on macrophage-expressed CD276 suggest that the antibody-dependent CD276 engagement triggers predominantly inhibitory signaling networks in human macrophages.
format article
author Sibel Durlanik
Katrin Fundel-Clemens
Coralie Viollet
Heinrich J. Huber
Martin Lenter
Kerstin Kitt
Stefan Pflanz
author_facet Sibel Durlanik
Katrin Fundel-Clemens
Coralie Viollet
Heinrich J. Huber
Martin Lenter
Kerstin Kitt
Stefan Pflanz
author_sort Sibel Durlanik
title CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for PAI-1
title_short CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for PAI-1
title_full CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for PAI-1
title_fullStr CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for PAI-1
title_full_unstemmed CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for PAI-1
title_sort cd276 is an important player in macrophage recruitment into the tumor and an upstream regulator for pai-1
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/3514e95bf4724fdea484cf4f1f37996c
work_keys_str_mv AT sibeldurlanik cd276isanimportantplayerinmacrophagerecruitmentintothetumorandanupstreamregulatorforpai1
AT katrinfundelclemens cd276isanimportantplayerinmacrophagerecruitmentintothetumorandanupstreamregulatorforpai1
AT coralieviollet cd276isanimportantplayerinmacrophagerecruitmentintothetumorandanupstreamregulatorforpai1
AT heinrichjhuber cd276isanimportantplayerinmacrophagerecruitmentintothetumorandanupstreamregulatorforpai1
AT martinlenter cd276isanimportantplayerinmacrophagerecruitmentintothetumorandanupstreamregulatorforpai1
AT kerstinkitt cd276isanimportantplayerinmacrophagerecruitmentintothetumorandanupstreamregulatorforpai1
AT stefanpflanz cd276isanimportantplayerinmacrophagerecruitmentintothetumorandanupstreamregulatorforpai1
_version_ 1718379037981671424